AlzeCure Pharma AB (publ)

kr 6.12As of Sun 8 Nov 2026, 12:00 UTC
STO:ALZCURHealthcare
Country Sweden
PE (Fwd) •••
TSR 8Y CAGR (3.64%)
Div yield —
ROE 62.85%
Biotechnology
Beta (5Y) (0.16)
PE TTM 22.67
TSR TTM 217.63%
Mkt cap kr 843.9M
ROIC 37.91%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 6.18
0.90%
6.68%
Sell 1|7|4|1|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.14
0.14
0.13
0.13
10.98%
11.32%
(0.12%)
(8.81%)
Revenuekr M
39.66
40.88
40.13
41.70
(1.30%)
3.30%
2.35%
4.95%
Peers (US$85.32M)
Cap (US$)
PE
86.51M
—
75.71M
—
Capital
TTM
5Y
10Y
Leveragex
2.925
0.039
0.027
EBIT/Intx
0.423
0.088
0.077
Own earn%
79.21
69.52
65.69
Sh yield%
41.11
24.61
25.42
Owners
Insiders/Inst%
14.91
71.65
Short interest%
5.18
SBC / revenue%
2.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
28–35
$1 testx
—
Incr. ROIC%
9